AADR vs CHNA

AADR is an ETF, whereas CHNA is a mutual fund. AADR has a higher expense ratio than CHNA (1.1% vs 0.79%). Below is the comparison between AADR and CHNA.

AADR CHNA
Security Type ETF Mutual fund
Segment Equity: Global Ex-U.S. - Total Market Growth N/A
Issuer AdvisorShares Loncar Investments
Net Assets $69.25M $10.5M
Expense Ratio 1.10% 0.79%
Management Style passive (index-based) passive
Dividend Yield 0.68% 0.15%
Minimum Investment N/A N/A
YTD Return 2.78% 24.32%
1-Year Return 11.52% 33.56%
3-Year Return 1.81% N/A
5-Year Return 9.50% N/A
10-Year Return 8.38% N/A

AADR description

The Fund seeks long-term capital appreciation above international benchmarks such as the MSCI EAFE Index and the BNY Mellon Classic ADR Index. The Fund selects a portfolio of U.S. traded securities of non-U.S. organizations, most often American Depositary Receipts (ADRs), included in the BNY Mellon Classic ADR Index.

AADR performance & returns

YTD Return 2.78%
1-Month Return -4.57%
3-Month Return 10.80%
1-Year Return 11.52%
3-Year Return 1.81%
5-Year Return 9.50%
10-Year Return 8.38%
AADR expense ratio is 1.1%.

AADR holdings

Top 10 Holdings (46.22% of Total Assets)

Name Symbol % Assets
MercadoLibre Inc MELI.SA 5.89%
argenx SE ADR ARGX 5.63%
NICE Ltd ADR NICE 5.45%
Gold Fields Ltd ADR GFI.JO 5.07%
Galapagos NV ADR GLPG 4.76%
Anglogold Ashanti Ltd ADR AU.JO 4.67%
ZTO Express (Cayman) Inc ADR ZTO 4.27%
TAL Education Group ADR TAL 3.75%
ASML Holding NV ADR ASML 3.67%
AstraZeneca PLC ADR AZN.L 3.06%

Other relevant AADR comparisons

You may also want to check out the following AADR comparisons that investors often look for on Finny

Or use Finny Compare Wizard to create a comparison you’d like to see.

CHNA description

The Fund seeks to track the performance of the Loncar China BioPharma Index. The Fund invests at least 80% of its assets in the component securities of the Index constructed from the universe of Nasdaq- or Hong Kong Stock Exchange-listed companies identified by the Index methodology as Biopharma Companies.

CHNA performance & returns

YTD Return 24.32%
1-Month Return -6.34%
3-Month Return 10.11%
1-Year Return 33.56%
3-Year Return N/A
5-Year Return N/A
10-Year Return N/A
CHNA expense ratio is 0.79%.

CHNA holdings

Top 10 Holdings (43.63% of Total Assets)

Name Symbol % Assets
CanSino Biologics Inc Class H 06185 6.51%
Shanghai Junshi Biosciences Co Ltd Class H 01877 5.26%
Wuxi AppTec Co Ltd 02359 4.35%
WuXi Biologics (Cayman) Inc Registered Shs Unitary 144A/Reg S 02269 4.24%
Sino Biopharmaceutical Ltd 01177.HK 4.10%
Innovent Biologics Inc 01801 4.09%
I-MAB ADR IMAB 4.07%
Hansoh Pharmaceutical Group Co Ltd 03692 3.95%
BeiGene Ltd ADR BGNE 3.61%
Zai Lab Ltd ADR Repr 1 Shs ZLAB 3.45%

Other relevant CHNA comparisons

You may also want to check out the following CHNA comparisons that investors often look for on Finny

    Or use Finny Compare Wizard to create a comparison you’d like to see.

    You can check out all comparisons Finny users have looked for here. Feel free to the browse the list and view the comparisons that are of an interest to you.

    7-day free trial: Get unlimited comparisons, and stock, ETF and mutual fund analyses for just $14.95 a month, without ads. Start a free trial. Go ad free!

    Follow Us